Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:APLS
Tag: NASDAQ:APLS
Apellis Pharmaceuticals Inc (NASDAQ:APLS) Insider Trading Activity – CEO Sold 5,000...
ME Staff
-
November 19, 2019
0
Apellis Pharmaceuticals Inc (NASDAQ:APLS) Insider Trading Activity – COO Sold 42,460...
ME Staff
-
September 27, 2019
0
Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Overweight by JPMorgan Chase...
ME Staff
-
July 12, 2019
0
Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets downgraded to Neutral by JPMorgan Chase...
ME Staff
-
January 23, 2019
0
Apellis Pharmaceuticals Inc (NASDAQ:APLS) had its Buy rating reiterated by Cantor...
ME Staff
-
December 20, 2018
0
Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target raised to $40.00 by Citigroup
ME Staff
-
December 6, 2018
0
Apellis Pharmaceuticals Inc (NASDAQ:APLS) price target set to $53.00 by Cantor...
ME Staff
-
December 3, 2018
0
Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Buy by B. Riley...
ME Staff
-
July 30, 2018
0
Analyst Downgrades – NASDAQ:APLS – Apellis Pharmaceuticals (NASDAQ:APLS) Stock Gets Downgraded...
ME Staff
-
April 12, 2018
0
Analyst Activity – JPMorgan Chase & Co. Raises Its Price Target...
ME Staff
-
March 23, 2018
0
1
2
Page 1 of 2
